Bayesian borrowing

R&D

Innovative trial designs that harness data augmentation, RWD, and the power of AI are enabling a new era of rare disease research.

Patients

Matt Wadyka, chief client strategy officer at Inizio Medical, spoke to pharmaphorum about the ins and outs of direct-to-patient programmes in pharma.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.